Retrospective component review, limitation review, and redesign of the evidence plan.
VitaSignal Interactive Product Tour
Turn a proposed clinical AI use case into a decision your healthcare organization can defend.
See how VitaSignal organizes intended use, data readiness, evidence, risk, controls, and unresolved questions into a versioned Governance Decision Package.
Product tour using generated data. No PHI.
Public worked example of the Clinical AI Documentation Readiness Evaluation.
Clinical AI Documentation Readiness Evaluation
One platform, two working surfaces, one versioned package.
The Governance Review Workspace holds the decision record. The Data Pathway Readiness Workspace establishes what the local documentation pathway can support. They are working surfaces within VitaSignal, not separate products.
- 01Scope the intended use
- 02Assess data readiness
- 03Review the evidence
- 04Connect risks to controls
- 05Form a recommendation
- 06Produce the decision package
Product tour scenarios
Explore a decision path
Scope the intended use
Working surface: Governance Review Workspace
Does an institutionally external retrospective confirmation of added discrimination support progression, given the adverse calibration and utility findings recorded in the same evaluation?
Read-only review of a documentation-derived component signal confirmed on an institutionally external retrospective record.
Clinical utility, patient benefit, generalizability, deployment readiness, or complete-product validation claims.
- ✓Frozen comparator and cutoff
- ✓Calibration and utility reporting
- ✓Missingness sensitivity
- ✓Demographic, hospital, and vendor fields
Evidence status
Generated examples, explicit boundaries.
Examples use generated data and do not establish clinical effectiveness. Retrospective or approved read-only review comes first; later observational work requires prespecified evidence gates and separate written authorization.